Expanding diagnostics business: SCHOTT signs agreement to acquire Applied Microarrays Inc.

SCHOTT MINIFAB, a subsidiary of SCHOTT that develops and manufactures microfluidic devices for point-of-care and life sciences consumables, has had a long-standing close customer relationship with Applied Microarrays Inc. (AMI). Together, they develop biotech substrates for diagnostics applications.

20/20 GeneSystems Launches First Accelerator Facility for Innovative Clinical Lab Tests

20/20 GeneSystems, Inc., (“20/20”), announced the launch of its Clinical Lab Innovation Axcellerator (CLIAx), believed to be the first shared CLIA laboratory facility geared to helping diagnostic test innovators worldwide substantially reduce the time and cost of launching their tests in the U.S.

TE Connectivity acquires three life science development and manufacturing firms; expands reach into IVD, point of care and microfluidics segments

TE Connectivity, a world leader in connectors and sensors, has acquired three companies focused on microfluidic cartridge and blister reagent package development, usability testing, clinical research and manufacturing. The companies are Toolbox Medical Innovations (USA), Wi Inc (USA) and microiLIQUID (Spain).

The combined entities leverage design and manufacturing capabilities in the United States and Europe and are focused on serving a global client base ranging from startups to multinationals in the life science, IVD and cell therapy markets.

Omega Bio-tek’s New Automation-Ready, Prefilled 96-Well Plates Kit Aims to Increase Convenience of DNA Purification

Omega Bio-tek, a leading nucleic acid purification kit manufacturer, releases an automation-ready, prefilled DNA extraction kit for magnetic processors to purify DNA faster and easier than before. The convenient Mag-Bind® Blood & Tissue DNA HDQ Prefilled 96 Kit comes prefilled with magnetic beads, reagent plates, and tip combs and aims to simplify setup and processing time for magnetic processors such as the Thermo Fisher Scientific KingFisher™ Flex, Qiagen BioSprint®, and the Applied Biosystems MagMax® Express-96.

Fapon Biotech First in World to Introduce COVID-19 Antibodies for Antigen Lateral Flow Testing in Differentiating Variant B.1.1.7 and Wild-Type Virus

Fapon Biotech, a mainstream COVID-19 raw materials supplier to the global top-profile reagent manufacturers, introduced pioneering COVID-19 antibodies for antigen lateral flow testing to detect and differentiate COVID-19 and the most notable variant B.1.1.7 (also known as SARS-CoV-2 VUI 202012/01) in human samples.

DiaPharma Announces Line-Up of Featured Products for AACC 2021

DiaPharma Group is pleased to announce our lineup of featured products during AACC 2021. Explore assays for COVID-19-associated coagulopathy, specialty hemostasis, organ injury, and SARS-CoV-2 serology. DiaPharma specializes in assays and mechanistic biomarkers for bleeding and clotting disorders, hemostasis analyzers, liver disease (Nonalcoholic Steatohepatitis, Alcoholic Hepatitis), drug-induced liver and kidney injury, and anti-cancer drug development.

U.S. Department of Energy’s Argonne National Laboratory and Hewlett Packard Enterprise prepare for exascale era with new testbed supercomputer

Argonne and HPE unveiled a new testbed supercomputer that will enable scientists and developers to test and optimize software codes and applications for the forthcoming exascale supercomputer, Aurora.

Wolters Kluwer and the American College of Surgeons announce publishing collaboration

Today, Wolters Kluwer, Health announced that it has entered into a multi-year agreement with the American College of Surgeons (ACS), a scientific and educational association of surgeons focused on improving the quality of care for the surgical patient. Wolters Kluwer will publish the Journal of the American College of Surgeons (JACS), ACS’s flagship clinical publication and one of the more highly cited surgery journals in the world with an impact factor of 6.113 and ranking 9/270 in the Surgery category, beginning in January 2022.

Light-Activated Dental Materials – the Latest Dental Innovation of International Standards from Chula

Chula Faculty members joined forces in dental materials science to develop easy-to-use “light-activated dental materials” that meet international standards and help shorten tooth filling time. The secret of these innovative dental materials, made by Thai people, is Acemannan polymer from Aloe Vera that can stimulate the formation of dentin and reduce tooth sensitivity in many dental health products.

Congress of Neurological Surgeons selects Wolters Kluwer as its publisher

Wolters Kluwer, Health announced a multi-year agreement reestablishing its collaboration with the Congress of Neurological Surgeons (CNS), the leading organization dedicated to advancing neurosurgery through education and innovation. Beginning in January 2022, Wolters Kluwer will publish three medical specialty journals from CNS’s portfolio including its flagship publication Neurosurgery, one of the most highly cited neurosurgery journals in the world.

2 in 1 Face Mask Against Dust and Virus – Chula Health Innovation in the New Normal

Chula’s Faculty of Engineering joins hands with PTT to develop a 2 in1 face mask, an innovation that protects against PM2.5 dust particles and COVID-19 virus that can be reused more than 15 times, helps reduce waste, is pollution-free, and will be available for sale soon.

Wolters Kluwer equips time-strapped clinicians with evidence-based orthopaedic research summaries from OrthoEvidence

To help clinicians stay current on orthopaedic and musculoskeletal research, Wolters Kluwer, Health announced today that Ovid® users will now have access to OrthoEvidence, a first of its kind evidence-based summary provider for orthopaedic specialists, surgeons, nurses, medical residents and students.

Corporate Employees Learn New Strategies for Helping Youth While Building Workforce of Tomorrow at CFES Brilliant Pathways Training

Corporations concerned with cultivating and recruiting the workforce of tomorrow due to the dramatic effects of COVID-19 on America’s youth are turning to CFES Brilliant Pathways for answers.

Case Western Reserve University biotech startup Rodeo Therapeutics Corp. sold to Amgen Inc.

Rodeo Therapeutics Corp., a drug-development startup founded by two leading researchers from the Case Western Reserve University School of Medicine and a third scientific partner, has been sold to Amgen Inc., a publicly traded international biopharmaceutical company.

Under terms of the agreement, Amgen, based in Thousand Oaks, California, will acquire all outstanding shares of Rodeo for $55 million, plus “future contingent milestone payments potentially worth up to an additional $666 million in cash,” the companies announced today. Total consideration to Rodeo stakeholders could potentially be worth up to $721 million in cash.

RGF® Environmental Group Releases Industry’s First Test Evaluating Aerosolized SARS-CoV-2 Viral Reductions Directly in the Air: PHI-PKG14 PHI-CELL® Proven to Inactivate 99.96% of Airborne SARS-CoV-2 within Simulated Air-Conditioned Space

RGF® Environmental Group, Inc., a leading environmental design and manufacturing company, has released the results of a third-party test that proves the PHI-PKG14 PHI-CELL® product with Photohydroionization® technology inactivates greater than 99.96% of airborne SARS-CoV-2 virus.

Microsoft features Case Western Reserve’s signature software for anatomy education at two online events

Case Western Reserve University’s HoloAnatomy® Software Suite will star this week in online events that Microsoft is hosting for colleges and universities– Tuesday, Jan. 26, in a webinar titled “A New Vision for Medical Education” and Wednesday, Jan. 27, in Microsoft’s HoloLens Industry Summit, which will include an education break-out session.

GenScript Granted Authorization for cPass™ SARS-CoV-2 Neutralization Antibody Detection Test in Brazil

GenScript USA Inc., the world’s leading research reagent provider, announced today that Brazil’s National Health Surveillance Agency (ANVISA) (Agência Nacional de Vigilância Sanitária) has authorized the use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit for detecting neutralizing antibodies. The cPass test is the first and only ANVISA authorized test for detecting neutralizing antibodies to SARS-CoV-2. Neutralizing antibodies specifically block the ability of a virus to infect a cell and are well-recognized to confer immunity.

Experience “Innovation Uninterrupted” with Sysmex America at AACC 2020

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, will be exhibiting virtually at the 72nd AACC Annual Scientific Meeting & Clinical Lab Expo, December 14 – 17.

AnteoTech enters high sensitivity Assay Development market built on proprietary AnteoBind™ technology.

AnteoTech marks its entry into the Assay Development market through the design of a high sensitivity COVID-19 Antigen Rapid Test. The test uses an AnteoBind™ activated Europium particle to enable the detection of low viral loads. AnteoTech is pleased to announce the expansion of its business to include Assay Development in addition to its existing Raw Material Supply business.

AACC Announces 2020 Corporate Supporter Award Winners; Thanks Organizations for Their Invaluable Support

AACC is pleased to announce the recipients of the AACC 2020 Top Corporate Supporter Awards. This year, AACC recognizes 45 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.